Lonza signs agreement with Canadian plant extracts
Canadian life science company, Fytokem Products Inc., a developer of therapeutic plant extracts and bioactive molecules, announced that it has signed a product development and licensing agreement with Lonza Inc., the US subsidiary of Swiss chemicals...